Inventaire - your friends and communities are your best library

Apoptosis: a link between cancer genetics and chemotherapy

author

Ricky W Johnstone

2000 -

published in: Cell

date of publication: 2002-01-01

language: English

main subject: chemotherapy, apoptotic process

Cites articles 80

Date

Title

Authors

2001-12-01

Proteasome inhibition in cancer: development of PS-341.
2001-02-01

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
2001-02-01

p53 upregulates cFLIP, inhibits transcription of NF-kappaB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells

Harald Wajant, Peter Scheurich
2001-01-01

Stress management - heat shock protein-70 and the regulation of apoptosis
2001-06-01

Unwinding the loop of Bcl-2 phosphorylation

Mikhail Blagosklonny
2001-09

BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis

Stanley J. Korsmeyer, Richard Flavell
2001-09-01

A Phase I trial of H-ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinoma
2001-05-17

Proliferation, cell cycle and apoptosis in cancer
2001-03-01

Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis

Simone Fulda, Klaus-Michael Debatin, Guido Kroemer, Santos A. Susin
2001-08-14

p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD

Stanley J. Korsmeyer
2001-11-01

Cellular stress response and apoptosis in cancer therapy

Klaus-Michael Debatin
2001-10

Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells

Bert Vogelstein, Kenneth W Kinzler
2001-07-01

Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells
2001-03-01

DNA double-strand breaks: signaling, repair and the cancer connection

Stephen P Jackson
2001-09-01

Chemoprotection from p53-dependent apoptosis: potential clinical applications of the p53 inhibitors
2001-11-01

Histone deacetylase inhibitors as new cancer drugs
2001-01-01

Breaking the mitochondrial barrier

Jean-Claude Martinou
2001-06

Apaf-1 is a transcriptional target for E2F and p53

Francesco Cecconi, Kristian Helin
2001-09-01

DNA methylation in genomic imprinting, development, and disease
2001-02-01

Phosphatidylinositol 3-kinases in tumor progression
2001-06-01

Regulation and function of the p53 tumor suppressor protein

Kevin M Ryan
2001-01-01

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

Manel Esteller, W. Richard McCombie
2001-09-11

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Michael B. Eisen, Patrick O. Brown, Per Eystein Lønning, Therese Sørlie, David Botstein, Anne-Lise Børresen-Dale, Hilde Johnsen, Charles M. Perou, Trevor Hastie, Robert Tibshirani, Matt van de Rijn, Stefanie S Jeffrey, Stephanie Geisler, Thor Thorsen, Turid Aas
2001-08-01

Regulation of PTEN transcription by p53

David MacPherson, Vuk Stambolic
2001-07-01

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis

Angela Rösen-Wolff, Elaine Jaffe
2001-09

A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death
2001-07-01

Telomerase activation by histone deacetylase inhibitor in normal cells
2001-01-01

Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells

Mark J. Smyth, Yoichiro Iwakura
2001-08-01

Antisense therapy in oncology: new hope for an old idea?

Gunther Hartmann
2001-04-01

Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process
2001-04-01

Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death

Vily Panoutsakopoulou, Kevin A. Roth, Stanley J. Korsmeyer
2001-06-27

Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity

Article - wd:Q34520432

Welcome to Inventaire

the library of your friends and communities

learn more